Search tips
Search criteria 


Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
Physiology (Bethesda). Author manuscript; available in PMC 2012 July 30.
Published in final edited form as:
PMCID: PMC3408074

Role of TRP Channels in the Regulation of the Endosomal Pathway


Some members of the transient receptor potential channel superfamily have proved to be essential in maintaining adequate ion homeostasis, signaling, and membrane trafficking in the endosomal pathway. The unique properties of the TRP channels confer cells the ability to integrate cytosolic and intraluminal stimuli and allow maintained and regulated release of Ca2+ from endosomes and lysosomes.

The role of ion channels in the endocytic pathway

The endosomal pathway is a highly compartmentalized system comprising numerous membrane-bound organelles that provides precise spatial and temporal regulation of various physiological processes (34). Endosomes and lysosomes receive cargo from the cell surface via endocytosis, biosynthetic cargo from the late Golgi complex, and various molecules from the cytoplasm via autophagy (12). The endosomal pathway is recognized as a key regulator of endocytic membrane traffic, protein sorting, and signaling. It also plays an essential role in a multitude of other cellular functions, including cell adhesion and migration, pathogen entry, neurotransmission, antigen presentation, and cell polarity.

During the last two decades the characterization of the sorting machinery that regulates the trafficking of proteins between different endosomal compartments has been at the forefront of the study of endosomal biology (13, 67). It has also become evident that the lipid composition of the endosomal membranes (i. e. rafts, phosphoinositides) plays a central role in both trafficking and signaling events. However, it is important to emphasize that the luminal composition of the endosomal organelles is also crucial for proper endosomal function. Luminal acidification is essential for the delivery and degradation of internalized ligands in lysosomes and regulates posttranslational modification and sorting of proteins along the endosomal pathway (56). Acidification must increase progressively from endocytic vesicles and early endosomes to late endosomes and lysosomes. Luminal Ca2+ is also a key regulator of the endosomal pathway. Release of Ca2+ from endosomes and lysosomes is required for several steps of intracellular trafficking, including fusion and fission events (54). Ca2+ efflux is also important for signal transduction, organelle homeostasis, and endosomal acidification (31). Moreover, defects on endosomal calcium homeostasis have been directly linked to several pathologies including acute pancreatitis (75) and Niemann-Pick Type C disease (52).

The luminal composition of endosomal organelles is maintained by specific channels that function as conduits for ions to cross the intracellular membranes. Recently, several members of the transient receptor potential (TRP) superfamily of ion channels have been localized to the endosomal pathway, where they participate in the regulation of vesicular ion homeostasis (Figure 1). TRP channels are a large family of cation channels with diverse physiological functions and cellular distributions (60). Most TRP channels act as sensors of changes in the extracellular environment, such as temperature, light, osmolarity, mechanical stress, or chemicals. However, some TRP channels respond to variations in the intracellular environment like pH or intracellular concentration of specific molecules (23). The activation of TRP channels may be directly mediated by physical or chemical stimuli or indirectly by second messengers generated by G protein-coupled or tyrosine kinase receptors. The TRP superfamily is divided into seven subfamilies (TRPC, TRPV, TRPM, TRPN, TRPA, TRPML, and TRPP) based on their sequence and structural organization (88). TRPs exhibit a common six-membrane-spanning topology with both the amino- and carboxy-terminal tails oriented toward the cytosol, and the pore located between transmembrane segments 5 and 6.

Figure 1
Overview of TRP channels in endosomal trafficking pathways

It was initially assumed that most TRPs function at the cell surface. However when heterologously expressed, many TRP channels localize, at least partially, to intracellular vesicles. In many cases, it is uncertain whether this vesicular distribution is physiologically relevant. Intracellular TRPs might represent newly synthesized molecules in transit to the plasma membrane or internalized channels being delivered to lysosomes for degradation. In addition, some channels accumulate in large and stable recycling pools close to the plasma membrane and are activated upon translocation to the cell surface. Therefore, to be considered a bona fide endosomal TRP we propose that the channel must follow at least one (or preferably all) of the following criteria: 1) presence of targeting motifs that mediate the sorting of the protein to the endosomal pathway, 2) channel activity recorded at endosome/lysosomes, and 3) defects on the endosomal pathway caused by absence or mutation of the endogenous protein (Figure 1).

TRPML1, a prototypical endo-lysosomal channel

TRPML1, also known as mucolipin-1 or MCOLN1, can be considered an example of an endosomal TRP channel as it complies with the three criteria mentioned above. First, several studies have established that both, endogenous and heterologously expressed TRPML1 distribute to the late endocytic pathway (42, 68, 82, 86, 94). Trafficking of TRPML1 to late endosomes/lysosomes is mediated by two consensus acidic di-leucine motifs located at the N- and C-terminal tails of the protein, respectively (68, 86, 94) (Figure 2). The di-leucine targeting motif at the N-tail (E11TERLL) directly interacts with clathrin adaptors AP1 and AP3. This interaction mediates direct sorting of TRPML1 from the trans-Golgi network (TGN) to the endosomal pathway. TRPML1 can also reach endosomes through an indirect pathway by traveling from TGN to the plasma membrane before being internalized and delivered to endosomes and subsequently to late endosomes/lysosomes. Endocytosis of TRPML1 from the cell surface is regulated by the di-leucine motif located at the C-terminal tail (E573EHSLL) and is dependent of clathrin and the clathrin adaptor AP2 (94).

Figure 2
Sorting and regulatory motifs in TRPML1

Second, TRPML1 activity has been recorded by direct patch-clamp of enlarged lysosomes isolated from vacuolin-treated cells (27). The intracellular distribution of TRPML1 made difficult the analysis of the selectivity and gating properties of this channel, leading to conflicting observations (reviewed in (69, 71)). However, the above mentioned recording of native endolysosomal membranes together with the use of a constitutive active mutant of TRPML1 (V432P) concluded that TRPML1 is an inwardly (from lumen to cytoplasm) rectifying channel permeable to Ca2+, Na+, K+ and Fe2+/ Mn2+ whose activity may be potentiated by low pH. Despite being a non-selective cation channel, it is thought that the main physiological function of TRPML1 is to facilitate Ca2+ efflux from late endosomes/lysosomes.

Third, mutations in TRPML1 results in Mucolipidosis type IV (MLIV) (5, 6, 77, 81), a lysosomal storage disorder characterized by severe neurological and ophthalmologic abnormalities (1, 2, 4). The first symptoms of the disease appear during the first year of life and include intellectual disabilities, psychomotor delay, weak muscle tone (hypotonia), corneal clouding, and progressive retinal degeneration (10, 70). MLIV patients also show impaired secretion of gastric acid (achlorhydria) leading to defective iron absorption and anemia (74). By their early teens, most affected individuals are unable to walk, present limited or no ability to speak, and have severe vision loss or blindness. Analysis of fibroblasts from MLIV patients by electron microscopy revealed the presence of enlarged vacuolar structures that accumulate mucopolysaccharides and lipids forming characteristic multiconcentric lamellae (10, 32, 70, 77). These enlarged vacuoles are present not only in fibroblasts but also in every tissue and organ of MLIV patients, indicating an ubiquitous impairment of the lysosomal function. Absence of TRPML1 function leads to abnormal lysosomal pH (although different laboratories have reported conflicting observations with regard to the lysosomal pH in MLIV cells) (58, 79), delayed retrograde trafficking of LacCer from lysosomes to TGN (18, 58, 68, 79), lipofuscin accumulation (57, 87), decreased fusion of lysosomes with the plasma membrane (48), lysosomal Fe2+ overload (27), and deficient autophagy (90). Indeed, MLIV fibroblasts as well as neurons from mouse and drosophila TRPML1 knockouts show accumulation of autophagosomes, ubiquitinated aggregates, p62 protein inclusions, and abnormal mitochondria, all of which are indicative of decreased autophagosome degradation (21, 36, 57, 87, 89, 90). It has been suggested that the combination of all these factors ultimately generate oxidative stress, causing the neuronal death and neurodegeneration observed in MLIV (19).

It is important to note that altered lipid trafficking, lipofuscin accumulation, defective autophagy, and oxidative stress are common to many lysosomal storage disorders (95). Therefore, a full understanding of TRPML1 function is dependent upon the clarification of its primary role as well as the initial events that trigger the pathological cascade in MLIV. Also of great importance will be to elucidate the mechanisms that regulate activation of this channel under physiological conditions (Figure 3). A key observation was recently reported by Dong et al. showing that TRPML1 activity is modulated by phosphoinositides (PIs) (28). By performing direct patch-clamping of endolysosomal membranes Dong et al. reported that PI(3,5)P2 strongly increases TRPML1 activity with high specificity. TRPML1 directly binds PI(3,5)P2 through several positive residues located in its N-terminus tail, thus undergoing conformational changes that favor its activation. The penta-EH-hand protein ALG-2 has also recently been identified as a TRPML1 modulator (91). ALG-2 directly binds the N-tail of TRPML1 only in the presence of Ca2+. Mutations in the ALG-2 binding domain significantly decreased the accumulation of enlarged lysosomes induced by TRPML1 over-expression, indicating that ALG-2 might act as a Ca2+ sensor that mediates or regulates trafficking events dependent on TRPML1 activity. Interestingly, ALG-2 interacts with some of the positive residues implicated in the binding to PI(3,5)P2. It will be important to determine whether the cross-talk between different TRPML1 modulators may provide a temporal control for TRPML1 activation. Finally, it has been suggested that nicotinic acid adenine dinucleotide phosphate (NAADP) might act as an activator of TRPML1 promoting the release of Ca2+ from lysosomes (99, 100). NAADP-dependent response was blocked by treatment with antibodies or siRNA against TRPML1. However, Pryor and Luzio reported that NADDP did not cause an increase in current in electrophysiology experiments on oocytes expressing TRPML1 (68). Moreover, the participation of TRPML1 in NAADP-mediated Ca2+ release is argued by the recent identification of the two-pore family of ion channels (TPC) as bona fide NAADP effectors at endosomes and late endosomes/lysosomes (14, 16). Still it is interesting to mention that treatment with Ned-19, a specific inhibitor of TPCs, rescues accumulation of enlarged lysosomes in MLIV cells (53), thus suggesting that TRPML1 might function as a regulator for TPCs.

Figure 3
Proposed model for TRPML activation

TRPML2 and TRPML3 also regulate endosomal function

In addition to TRPML1, the mucolipin family in mammals includes two other members, TRPML2 and TRPML3. Immunofluorescence and cellular fractionation techniques have established that both endogenous and recombinant TRPML3 localize mainly to early and late endosomes/lysosomes and to a lesser extent, to the plasma membrane (40, 55, 59, 96, 97). Whole-cell patch-clamp techniques in cells heterologously expressing TRPML3 revealed that the protein function as an inwardly rectifying Ca2+-permeable cation channel which activity is inhibited by acidic extracellular (or luminal) pH and increased by incubation of cells in low Na+ (20, 39, 40, 59, 96). TRPML3 shows some permeability to Fe2+ but to a less degree than TRPML1 or TRPML2 (27). As in the case of TRPML1, recombinant TRPML3 currents have been measured in whole-endolysosomal membranes and the activity of the channel dramatically increases in the presence of PI(3, 5)P2, thus indicating that PIs are common regulators of TRPML function (28). The recent identification of several selective activators of TRPML3 will hopefully provide revealing information on the properties of the endogenous protein (33). Interestingly, gain-of-function mutations in TRPML3 result in the varitint-waddler (Va) phenotype in mice, which is characterized by hearing loss, vestibular dysfunction (circling behavior, head-bobbing, waddling), and coat color dilution (25). This Va phenotype is caused by a point mutation (V419P) in the pore region that locks the channel in an open conformation (39, 59, 96). The Va mutant causes massive entry of Ca2+ inside cells leading to apoptosis and cell death. It has been further proposed that death of melanocytes in the inner ear and the skin (two tissues in which the expression of TRPML3 is high) might be responsible for the hearing problems and the coat color dilution observed in varitint-waddler mice (96).

Over-expression of TRPML3 causes severe alterations in the endosomal pathway, including enlargement and clustering of endosomes, delayed Epidermal Growth Factor Receptor (EGFR) degradation, and impaired autophagosome maturation, thus suggesting that TRPML3 is an important regulator of endosomal function (41, 55). Moreover, inhibition of TRPML3 function by expression of a channel-dead dominant negative mutant (458DD/KK) or by knockdown of endogenous TRPML3 results in a significant accumulation of luminal Ca2+ at endosomes, severe defects in endosomal acidification, and increased endosomal fusion (our unpublished observations). Depletion of endogenous TRPML3 also affects lysosomal integrity and autophagy (41, 97). Therefore, it has been proposed that TRPML3 mediates regulated Ca2+ release from endosomal compartments and its function is crucial for preserving proper Ca2+ homeostasis, endosomal pH, and membrane trafficking (55).

Similar to TRPML3, TRPML2 partially localizes to late endosomes/lysosomes when expressed in a variety of cell lines (38, 78, 86). In Hela cells, recombinant TRPML2 also distributes at the cell surface and along the tubular recycling endosomes of the Arf6-regulated pathway (26, 38). In agreement with these studies, only a fraction of endogenous TRPML2 co-localizes with LAMP1-positive vesicles while the remaining protein distributes into vesicular structures that likely correspond to the early or recycling endosomes (97). The channel properties and function of TRPML2 are much less characterized than those of TRPML1 or TRPML3, albeit expression of TRPML2 in drosophila S2 cells suggests that the channel displays nonselective cation permeability, which is Ca2+-permeable and inhibited by low extracytosolic pH (49). TRPML2-mediated currents have also been recorded in endolysosomal membranes, suggesting a role for this channel at the endosomal pathway (28). This possibility is supported by recent evidence showing that expression of a dominant-negative version of TRPML2 (D463D/KK) considerably reduces recycling of internalized CD59 to the cell surface, thus indicating that TRPML2 might regulate transport of certain glycosylphosphatidylinositol-anchored proteins through the Arf6 pathway (38). In addition, depletion of endogenous TRPML2 results in the accumulation of lysosomal inclusions (97). Therefore, TRPML2 may play a role at both the early and late endocytic pathway.

In mice, two alternative-spliced variants of TRPML2 have been described that differ in the presence (long variant or TRPML2lv) or absence (short variant or TRPML2sv) of 28 residues at the N-terminal tail of the protein (73). While expression of TRPML2lv is very low in most analyzed mouse tissues, TRPML2sv has a predominant expression in lymphoid and kidney organs. TRPML2 is also detected in B-lymphocytes and its expression is regulated by the Bruton’s tyrosine kinase, a crucial protein in B-lymphocyte development, suggesting that TRPML2 might play a role in the regulation of immune response (50, 78). The levels of TRPML2sv (but not TRPML2lv) are considerably reduced in the TRPML1 knockout mouse, indicating that TRPML1 acts as a transcriptional regulator of TRPML2 (73). In humans, only one TRPML2 isoform, seemly corresponding to the TRPML2lv, has been detected. Therefore, the possibility that a reduction in the levels of TRPML2 might contribute to some of the clinical manifestations of MLIV still remains uncertain.

Hetero-multimerization between the members of the TRPML family upon over-expression has been detected by FRET analysis and co-immunoprecipitation (86). More recently, reconstitution of in vitro translated TRPMLs in synthetic lipid-bilayers showed that hetero-multimers display distinct electrophysiological properties when compared to homo-multimers (22), indicating that interaction between TRPML proteins modifies channel function. Hetero-multimerization of recombinant TRPMLs has also proven to modulate several cellular processes regulated by TRPMLs, such as cell viability and autophagy (98). However, the formation of hetero-oligomers between endogenous TRPMLs is limited as TRPML2 and TRPML3 only partially co-localize with TRPML1 in late endosomes/lysosomes (97). Therefore, it is plausible that combinations of homo- and hetero-multimers co-exist in cells, with each exhibiting unique channel properties and cellular functions. TRPMLs may also form hetero-oligomers with other endolysosomal transmembrane proteins. Co-immunoprecipitation and yeast two-hybrid assays showed that TRPML1 (but no TRPML3) interacts with a family of lysosome-associated transmembrane proteins (LAPTM) implicated in the transport of various molecules across the lysosomal membranes (92). Future studies should determine the physiological relevance of this interaction and the suitability of LAPTMs as potential therapeutic targets for MLIV.

In summary, current evidence suggests that TRPMLs mediate transient, regulated, and localized Ca2+ efflux from acidic stores, while activation by pH and PIs may provide specific spatio-temporal regulation for each TRPML along the endosomal pathway. Release of luminal Ca2+ plays a pivotal role in several trafficking events such as fusion (or fission) of lysosomes with autophagosomes, late endosomes, or plasma membrane. Therefore, TRPMLs are important regulators of membrane trafficking in the endosomal pathway (Figure 3). TRPMLs are also permeable to Na+, K+ and Fe2+/ Mn2+, thus suggesting that this family of proteins may contribute in additional ways to maintain vesicular ion homeostasis.

Other TRP channels at the endocytic pathway

Current evidence with respect to the role of other TRP channels in the endosomal pathway is less compelling than for TRPMLs. Still, several members from various TRP subfamilies are good candidates for future study given both their presence and/or association with endosomal membranes as well as recent findings on their physiological roles within these compartments.

Along with members of the TRPML subfamily, the TRPM2 channel is the only other known TRP channel that is found in late endosomes and lysosomes in mammals (47). TRPM2 is a chanzyme, meaning that it is a cation channel fused with an enzymatic ADP-ribose pyrophosphatase domain. TRPM2 is non-selective for cations, permeable to Ca2+, and has a dual function both at the plasma membrane and at lysosomes (47). At the cell surface, TRPM2 operates as a Ca2+-influx channel allowing entry of Ca2+ inside the cell and the regulation of numerous biological effects including insulin secretion, detection of oxidative stress and apoptosis, increased plasma membrane permeability in endothelium, and the production of cytokines (37). TRPM2 channel activity is modulated by oxidative stress and ADP-ribose, which is converted into AMP by the ADP-ribose phyrophosphatase domain of TRPM2 (64, 65). Other known regulators of TRPM2 include cyclic ADP-ribose (45), reactive oxygen species (35), pH (80), intracellular Ca2+ (64), and NAADP (7). However, it is important to point out that a recent report by Toth and Csanady indicates that physiologically relevant concentrations of NAADP or cyclic ADP-ribose do not activate TRPM2 (83). Future studies will hopefully resolve these discrepancies. Several lines of evidence suggest that TRPM2 may also function as a lysosomal Ca2+-release channel in pancreatic beta cells (47). First, endogenous TRPM2 localizes to lysosomes in INS-1 beta cells. Second, Ca2+ release mediated by ADP-ribose is reduced in cells from TRPM2 knockout mice or cells treated with small interfering RNA (siRNA) against TRPM2. Third, ADP-ribose mediated Ca2+ release is blocked by treatment with agents like bafilomycin that empty acidic Ca2+ stores. It has been suggested that the release of intracellular Ca2+ from lysosomes upon TRPM2 activation plays a critical role in hydrogen peroxide–induced cell death in beta cells (47).

Heterologous expression of several alternative splice variants of TRPM1 revealed that all the isoforms distribute along a very dynamic network of intracellular tubular structures (61), suggesting a possible role of this channel at the endosomal pathway. TRPM1 is thought to be an indicator of melanoma aggressiveness and its expression is severely reduced in highly metastatic cell lines (29, 30). However, the role of TRPM1 in the regulation of melanosome trafficking or biogenesis is still a matter of debate, as TRPM1 was not found to co-localize with melanosomes in SK-Mel19 cell preparations (61). In addition, TRPM1 has been implicated in pigmentation in horses (9) but no coat color alterations has been reported in TRPM1 knockout mice (44). More recently it has been shown that mutations in TRPM1 are associated with congenital stationary night blindness in humans and that TRPM1 plays a crucial role in mediating a photo response in retinal ON bipolar cells (43).

TRPM7 might also have a potential role in intracellular trafficking. In sympathetically derived cells, TRMP7 is contained in synaptic vesicles where it may play several potential roles in vesicular content release. First, TRPM7 could serve to ionically balance neurotransmitters destined for exocytic release (46). Secondly, this channel might also modulate vesicular release through regulation of the membrane potential (46). Lastly, as proposed by Brauchi et al., upon binding to PI(4,5)P2 in the plasma membrane, TRPM7 is activated allowing for conductance of ions including Ca2+, thus acting as a critical mediator of vesicle fusion events (15).

Within the TRPV subfamily, TRPV2 is probably the best candidate so far to play a role in the endosomal pathway. After performing patch clamp in early endosomes enlarged by expression of a hydrolysis-deficient Vps4 mutant, Saito et al. reported the presence of a calcium channel in early endosomes whose properties matches those of TRPV2 (activation by 2-aminoethyldiphenyl borate and inhibition by Ruthenium Red) (72). TRPV2 current is activated by acidification and decrease in chloride luminal concentration, two processes that rapidly occur after pinching and conversion of endocytic vesicles into early endosomes. Therefore, as in the case of TRPML3, release of Ca2+ from early endosomes mediated by TRPV2 may regulate Ca2+-dependent fusion between endosomal membranes and proper endosomal acidification. The role of TRPV2 in trafficking was further reinforced by recent evidence showing that early phagocytosis is impaired in TRPV2 knockout macrophages (51). TRPV2 may also function at the cell surface. Insulin accelerates exocytosis by promoting activation and translocation of TRPV2 from intracellular vesicles to the plasma membrane in a PI3K-dependent manner in pancreatic beta cells (3). Finally, TRPV2 is also activated by noxious heat and stretch and is thought to play a role as a mechano-sensor in vascular smooth muscle cells (8).

Less clear is the role of TRPV5 and TRPV6 in recycling endosomes. Both channels are constitutively active, highly Ca2+ selective, and play an important role in Ca2+ uptake from apical cell surfaces in the kidney (TRPV5) and in the small intestine (TRPV6) (85). Recent evidence has shown a direct interaction of TRPV5 and TRPV6 with Rab11, a small GTPase that regulates trafficking of multiple molecules from recycling endosomes to the cell surface (84). TRPV5 co-localizes with Rab11 in vesicular structures and expression of a Rab11 mutant locked into its inactive GDP-state decreases the amount of TRPV5 and TRPV6 and the plasma membrane (84, 85). As of yet, however, there is no conclusive evidence that TRPV5 and TRPV6 are functional in recycling endosomes. Most likely, the accumulation of these channels in endosomes reflects a way for the cell to regulate their expression (and thereby activity) at the cell surface. This might also be the case of TRPC3 and TRPC5 as they mostly reside in intracellular vesicles but translocate to the cell surface in response to activation of G-protein coupled receptors or stimulation with growth factors, respectively (11, 76).

TRPY1 (also known as YVC1) is the only member of the TRP superfamily expressed in yeast. TRPY1 is found exclusively in vacuoles, an organelle equivalent to mammalian lysosomes that in yeast constitutes the main storage for intracellular Ca2+ (63). It has been proposed that TRPY1 functions as a mechanosensitive ion channel, releasing vacuolar Ca2+ in response to osmotic changes in vivo (24) and to membrane stretch force under patch clamp (101). Yeast strains deficient for TRPY1 do not show any apparent growth defects under normal or stressed conditions but they fail to induce an increase in cytosolic Ca2+ after hypotonic treatment. In addition, yeast over-expressing TRPY1 become more sensitive to the presence of CaCl2 (but not MgCl2, NaCl, or KCl) in the medium (17). Therefore, it seems clear that TRPY1 plays an important role in the regulated release of intraluminal Ca2+ from vacuoles.

Concluding remarks

TRP channels at the plasma membrane chiefly mediate their effects by controlling the concentration of free intracellular calcium, which acts as a second messenger inside the cell. Recently, it has become evident that TRP channels can also regulate Ca2+ efflux from acidic stores. This Ca2+ release is essential for maintaining proper ion homeostasis and membrane trafficking along the endosomal pathway. Considering the increasing number of signaling molecules found to be associated with endosomal membranes, it is likely that Ca2+ efflux also plays a crucial role in signal transduction and formation of signaling scaffolding complexes. The activity of the endosomal TRP channels can be regulated by cytosolic second messengers, by the biophysical-chemical properties of the endosomal membranes (PIs and stretch), and by the luminal composition of the endosomal organelles (pH and Ca2+ concentration). Therefore, like their counterparts at the cell surface, endosomal TRP channels can respond to variations in their environment and integrate signals coming from the cytosol and the lumen of endosomes and lysosomes. The fact that the only TRP channel identified in yeast localizes to the vacuole and mediates Ca2+ release strengthens the importance of this family of ion channels in the maintenance of the ionic composition of the endocytic compartments. Still, our understanding of how TRP channels function in regulating signaling and other trafficking pathways is limited. Thus for example, not much is known regarding the ability of TRP channels to form hetero-oligomers with members of other TRP subfamilies or their interaction with endosomal regulatory proteins. In addition, it is important to point out that other families of channels, like TPCs, may also play an important role in the regulation of Ca2+ efflux from acidic stores. Ultimately, clarifying the function of endosomal TRP channels in specific cell types will allow us to understand what role these channels play in a multitude of normal homeostatic functions, and these key discoveries will undoubtedly help us gain insight into various human diseases that currently have limited or no available treatment options.


We thank all the members of the laboratory for their comment and helpful discussions. We apologize to colleagues whose studies were not cited due to space limitations. In some cases review articles were cited at the expense of the original contributions.

This project was supported by the Intramural Research Program of the NIH, National Heart, Lung, and Blood Institute (NHLBI).


This review focus on the member of the transient receptor potential superfamily of ion channels that localize and function at the endosomal pathway


1. Altarescu G, Sun M, Moore DF, Smith JA, Wiggs EA, Solomon BI, Patronas NJ, Frei KP, Gupta S, Kaneski CR, Quarrell OW, Slaugenhaupt SA, Goldin E, Schiffmann R. The neurogenetics of mucolipidosis type IV. Neurology. 2002;59:306–313. [PubMed]
2. Amir N, Zlotogora J, Bach G. Mucolipidosis type IV: clinical spectrum and natural history. Pediatrics. 1987;79:953–959. [PubMed]
3. Aoyagi K, Ohara-Imaizumi M, Nishiwaki C, Nakamichi Y, Nagamatsu S. Insulin/phosphatidylinositol 3-kinase pathway accelerates the glucose-induced first phase insulin secretion through TrpV2 recruitment in pancreatic beta-cells. Biochem J. 2010 [PubMed]
4. Bach G. Mucolipidosis type IV. Mol Genet Metab. 2001;73:197–203. [PubMed]
5. Bargal R, Avidan N, Ben-Asher E, Olender Z, Zeigler M, Frumkin A, Raas-Rothschild A, Glusman G, Lancet D, Bach G. Identification of the gene causing mucolipidosis type IV. Nat Genet. 2000;26:118–123. [PubMed]
6. Bassi MT, Manzoni M, Monti E, Pizzo MT, Ballabio A, Borsani G. Cloning of the gene encoding a novel integral membrane protein, mucolipidin-and identification of the two major founder mutations causing mucolipidosis type IV. Am J Hum Genet. 2000;67:1110–1120. [PubMed]
7. Beck A, Kolisek M, Bagley LA, Fleig A, Penner R. Nicotinic acid adenine dinucleotide phosphate and cyclic ADP-ribose regulate TRPM2 channels in T lymphocytes. FASEB J. 2006;20:962–964. [PubMed]
8. Beech DJ, Muraki K, Flemming R. Non-selective cationic channels of smooth muscle and the mammalian homologues of Drosophila TRP. J Physiol. 2004;559:685–706. [PubMed]
9. Bellone RR, Brooks SA, Sandmeyer L, Murphy BA, Forsyth G, Archer S, Bailey E, Grahn B. Differential gene expression of TRPM1, the potential cause of congenital stationary night blindness and coat spotting patterns (LP) in the Appaloosa horse (Equus caballus) Genetics. 2008;179:1861–1870. [PubMed]
10. Berman ER, Livni N, Shapira E, Merin S, Levij IS. Congenital corneal clouding with abnormal systemic storage bodies: a new variant of mucolipidosis. J Pediatr. 1974;84:519–526. [PubMed]
11. Bezzerides VJ, Ramsey IS, Kotecha S, Greka A, Clapham DE. Rapid vesicular translocation and insertion of TRP channels. Nat Cell Biol. 2004;6:709–720. [PubMed]
12. Bishop NE. Dynamics of endosomal sorting. Int Rev Cytol. 2003;232:1–57. [PubMed]
13. Bonifacino JS, Traub LM. Signals for sorting of transmembrane proteins to endosomes and lysosomes. Annu Rev Biochem. 2003;72:395–447. [PubMed]
14. Brailoiu E, Churamani D, Cai X, Schrlau MG, Brailoiu GC, Gao X, Hooper R, Boulware MJ, Dun NJ, Marchant JS, Patel S. Essential requirement for two-pore channel 1 in NAADP-mediated calcium signaling. J Cell Biol. 2009;186:201–209. [PMC free article] [PubMed]
15. Brauchi S, Krapivinsky G, Krapivinsky L, Clapham DE. TRPM7 facilitates cholinergic vesicle fusion with the plasma membrane. Proc Natl Acad Sci U S A. 2008;105:8304–8308. [PubMed]
16. Calcraft PJ, Ruas M, Pan Z, Cheng X, Arredouani A, Hao X, Tang J, Rietdorf K, Teboul L, Chuang KT, Lin P, Xiao R, Wang C, Zhu Y, Lin Y, Wyatt CN, Parrington J, Ma J, Evans AM, Galione A, Zhu MX. NAADP mobilizes calcium from acidic organelles through two-pore channels. Nature. 2009;459:596–600. [PMC free article] [PubMed]
17. Chang Y, Schlenstedt G, Flockerzi V, Beck A. Properties of the intracellular transient receptor potential (TRP) channel in yeast, Yvc1. FEBS Lett. 2010;584:2028–2032. [PubMed]
18. Chen CS, Bach G, Pagano RE. Abnormal transport along the lysosomal pathway in mucolipidosis, type IV disease. Proc Natl Acad Sci U S A. 1998;95:6373–6378. [PubMed]
19. Cheng X, Shen D, Samie M, Xu H. Mucolipins: Intracellular TRPML1-3 channels. FEBS Lett. 2010;584:2013–2021. [PMC free article] [PubMed]
20. Cuajungco MP, Samie MA. The varitint-waddler mouse phenotypes and the TRPML3 ion channel mutation: cause and consequence. Pflugers Arch. 2008;457:463–473. [PubMed]
21. Curcio-Morelli C, Charles FA, Micsenyi MC, Cao Y, Venugopal B, Browning MF, Dobrenis K, Cotman SL, Walkley SU, Slaugenhaupt SA. Macroautophagy is defective in mucolipin-1-deficient mouse neurons. Neurobiol Dis. 2010;40:370–377. [PubMed]
22. Curcio-Morelli C, Zhang P, Venugopal B, Charles FA, Browning MF, Cantiello HF, Slaugenhaupt SA. Functional multimerization of mucolipin channel proteins. J Cell Physiol. 2010;222:328–335. [PubMed]
23. Damann N, Voets T, Nilius B. TRPs in our senses. Curr Biol. 2008;18:R880–R889. [PubMed]
24. Denis V, Cyert MS. Internal Ca(2+) release in yeast is triggered by hypertonic shock and mediated by a TRP channel homologue. J Cell Biol. 2002;156:29–34. [PMC free article] [PubMed]
25. Di Palma F, Belyantseva IA, Kim HJ, Vogt TF, Kachar B, Noben-Trauth K. Mutations in Mcoln3 associated with deafness and pigmentation defects in varitint-waddler (Va) mice. Proc Natl Acad Sci U S A. 2002;99:14994–14999. [PubMed]
26. Donaldson JG. Multiple roles for Arf6: sorting, structuring, and signaling at the plasma membrane. J Biol Chem. 2003;278:41573–41576. [PubMed]
27. Dong XP, Cheng X, Mills E, Delling M, Wang F, Kurz T, Xu H. The type IV mucolipidosis-associated protein TRPML1 is an endolysosomal iron release channel. Nature. 2008;455:992–996. [PubMed]
28. Dong XP, Shen D, Wang X, Dawson T, Li X, Zhang Q, Cheng X, Zhang Y, Weisman LS, Delling M, Xu H. PI(3,5)P(2) Controls Membrane Traffic by Direct Activation of Mucolipin Ca Release Channels in the Endolysosome. Nat Commun. 2010;1 [PMC free article] [PubMed]
29. Duncan LM, Deeds J, Cronin FE, Donovan M, Sober AJ, Kauffman M, McCarthy JJ. Melastatin expression and prognosis in cutaneous malignant melanoma. J Clin Oncol. 2001;19:568–576. [PubMed]
30. Duncan LM, Deeds J, Hunter J, Shao J, Holmgren LM, Woolf EA, Tepper RI, Shyjan AW. Down-regulation of the novel gene melastatin correlates with potential for melanoma metastasis. Cancer Res. 1998;58:1515–1520. [PubMed]
31. Gerasimenko JV, Tepikin AV, Petersen OH, Gerasimenko OV. Calcium uptake via endocytosis with rapid release from acidifying endosomes. Curr Biol. 1998;8:1335–1338. [PubMed]
32. Goldin E, Cooney A, Kaneski CR, Brady RO, Schiffmann R. Mucolipidosis IV consists of one complementation group. Proc Natl Acad Sci U S A. 1999;96:8562–8566. [PubMed]
33. Grimm C, Jors S, Saldanha SA, Obukhov AG, Pan B, Oshima K, Cuajungco MP, Chase P, Hodder P, Heller S. Small molecule activators of TRPML3. Chem Biol. 2010;17:135–148. [PMC free article] [PubMed]
34. Gruenberg J. The endocytic pathway: a mosaic of domains. Nat Rev Mol Cell Biol. 2001;2:721–730. [PubMed]
35. Hara Y, Wakamori M, Ishii M, Maeno E, Nishida M, Yoshida T, Yamada H, Shimizu S, Mori E, Kudoh J, Shimizu N, Kurose H, Okada Y, Imoto K, Mori Y. LTRPC2 Ca2+-permeable channel activated by changes in redox status confers susceptibility to cell death. Mol Cell. 2002;9:163–173. [PubMed]
36. Jennings JJ, Jr, Zhu JH, Rbaibi Y, Luo X, Chu CT, Kiselyov K. Mitochondrial aberrations in mucolipidosis Type IV. J Biol Chem. 2006;281:39041–39050. [PubMed]
37. Jiang LH, Yang W, Zou J, Beech DJ. TRPM2 channel properties, functions and therapeutic potentials. Expert Opin Ther Targets. 2010;14:973–988. [PubMed]
38. Karacsonyi C, Miguel AS, Puertollano R. Mucolipin-2 localizes to the Arf6-associated pathway and regulates recycling of GPI-APs. Traffic. 2007;8:1404–1414. [PubMed]
39. Kim HJ, Li Q, Tjon-Kon-Sang S, So I, Kiselyov K, Muallem S. Gain-of-function mutation in TRPML3 causes the mouse Varitint-Waddler phenotype. J Biol Chem. 2007;282:36138–36142. [PubMed]
40. Kim HJ, Li Q, Tjon-Kon-Sang S, So I, Kiselyov K, Soyombo AA, Muallem S. A novel mode of TRPML3 regulation by extracytosolic pH absent in the varitint-waddler phenotype. EMBO J. 2008;27:1197–1205. [PubMed]
41. Kim HJ, Soyombo AA, Tjon-Kon-Sang S, So I, Muallem S. The Ca(2+) channel TRPML3 regulates membrane trafficking and autophagy. Traffic. 2009;10:1157–1167. [PMC free article] [PubMed]
42. Kiselyov K, Chen J, Rbaibi Y, Oberdick D, Tjon-Kon-Sang S, Shcheynikov N, Muallem S, Soyombo A. TRP-ML1 is a lysosomal monovalent cation channel that undergoes proteolytic cleavage. J Biol Chem. 2005;280:43218–43223. [PubMed]
43. Koike C, Numata T, Ueda H, Mori Y, Furukawa T. TRPM1: A vertebrate TRP channel responsible for retinal ON bipolar function. Cell Calcium. 2010;48:95–101. [PubMed]
44. Koike C, Obara T, Uriu Y, Numata T, Sanuki R, Miyata K, Koyasu T, Ueno S, Funabiki K, Tani A, Ueda H, Kondo M, Mori Y, Tachibana M, Furukawa T. TRPM1 is a component of the retinal ON bipolar cell transduction channel in the mGluR6 cascade. Proc Natl Acad Sci U S A. 2010;107:332–337. [PubMed]
45. Kolisek M, Beck A, Fleig A, Penner R. Cyclic ADP-ribose and hydrogen peroxide synergize with ADP-ribose in the activation of TRPM2 channels. Mol Cell. 2005;18:61–69. [PubMed]
46. Krapivinsky G, Mochida S, Krapivinsky L, Cibulsky SM, Clapham DE. The TRPM7 ion channel functions in cholinergic synaptic vesicles and affects transmitter release. Neuron. 2006;52:485–496. [PubMed]
47. Lange I, Yamamoto S, Partida-Sanchez S, Mori Y, Fleig A, Penner R. TRPM2 functions as a lysosomal Ca2+-release channel in beta cells. Sci Signal. 2009;2:ra23. [PMC free article] [PubMed]
48. LaPlante JM, Sun M, Falardeau J, Dai D, Brown EM, Slaugenhaupt SA, Vassilev PM. Lysosomal exocytosis is impaired in mucolipidosis type IV. Mol Genet Metab. 2006;89:339–348. [PubMed]
49. Lev S, Zeevi DA, Frumkin A, Offen-Glasner V, Bach G, Minke B. Constitutive activity of the human TRPML2 channel induces cell degeneration. J Biol Chem. 2010;285:2771–2782. [PMC free article] [PubMed]
50. Lindvall JM, Blomberg KE, Wennborg A, Smith CI. Differential expression and molecular characterisation of Lmo7, Myo1e, Sash1, and Mcoln2 genes in Btk-defective B-cells. Cell Immunol. 2005;235:46–55. [PubMed]
51. Link TM, Park U, Vonakis BM, Raben DM, Soloski MJ, Caterina MJ. TRPV2 has a pivotal role in macrophage particle binding and phagocytosis. Nat Immunol. 2010;11:232–239. [PMC free article] [PubMed]
52. Lloyd-Evans E, Morgan AJ, He X, Smith DA, Elliot-Smith E, Sillence DJ, Churchill GC, Schuchman EH, Galione A, Platt FM. Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium. Nat Med. 2008;14:1247–1255. [PubMed]
53. Lloyd-Evans E, Peterneva K, Lewis A, Churchill G, Platt F. Abnormal lysosomal calcium homeostasis in mucolipidosis type IV. Molecular Genetics and Metabolism. 2008;93:29–30.
54. Luzio JP, Bright NA, Pryor PR. The role of calcium and other ions in sorting and delivery in the late endocytic pathway. Biochem Soc Trans. 2007;35:1088–1091. [PubMed]
55. Martina JA, Lelouvier B, Puertollano R. The calcium channel mucolipin-3 is a novel regulator of trafficking along the endosomal pathway. Traffic. 2009;10:1143–1156. [PMC free article] [PubMed]
56. Mellman I, Fuchs R, Helenius A. Acidification of the endocytic and exocytic pathways. Annu Rev Biochem. 1986;55:663–700. [PubMed]
57. Micsenyi MC, Dobrenis K, Stephney G, Pickel J, Vanier MT, Slaugenhaupt SA, Walkley SU. Neuropathology of the Mcoln1(−/−) knockout mouse model of mucolipidosis type IV. J Neuropathol Exp Neurol. 2009;68:125–135. [PubMed]
58. Miedel MT, Rbaibi Y, Guerriero CJ, Colletti G, Weixel KM, Weisz OA, Kiselyov K. Membrane traffic and turnover in TRP-ML1-deficient cells: a revised model for mucolipidosis type IV pathogenesis. J Exp Med. 2008;205:1477–1490. [PMC free article] [PubMed]
59. Nagata K, Zheng L, Madathany T, Castiglioni AJ, Bartles JR, Garcia-Anoveros J. The varitint-waddler (Va) deafness mutation in TRPML3 generates constitutive, inward rectifying currents and causes cell degeneration. Proc Natl Acad Sci U S A. 2008;105:353–358. [PubMed]
60. Nilius B, Owsianik G. Transient receptor potential channelopathies. Pflugers Arch. 2010;460:437–450. [PubMed]
61. Oancea E, Vriens J, Brauchi S, Jun J, Splawski I, Clapham DE. TRPM1 forms ion channels associated with melanin content in melanocytes. Sci Signal. 2009;2:ra21. [PubMed]
62. Okumura M, Ichioka F, Kobayashi R, Suzuki H, Yoshida H, Shibata H, Maki M. Penta-EF-hand protein ALG-2 functions as a Ca2+-dependent adaptor that bridges Alix and TSG101. Biochem Biophys Res Commun. 2009;386:237–241. [PubMed]
63. Palmer CP, Zhou XL, Lin J, Loukin SH, Kung C, Saimi Y. A TRP homolog in Saccharomyces cerevisiae forms an intracellular Ca(2+)-permeable channel in the yeast vacuolar membrane. Proc Natl Acad Sci U S A. 2001;98:7801–7805. [PubMed]
64. Perraud AL, Fleig A, Dunn CA, Bagley LA, Launay P, Schmitz C, Stokes AJ, Zhu Q, Bessman MJ, Penner R, Kinet JP, Scharenberg AM. ADP-ribose gating of the calcium-permeable LTRPC2 channel revealed by Nudix motif homology. Nature. 2001;411:595–599. [PubMed]
65. Perraud AL, Takanishi CL, Shen B, Kang S, Smith MK, Schmitz C, Knowles HM, Ferraris D, Li W, Zhang J, Stoddard BL, Scharenberg AM. Accumulation of free ADP-ribose from mitochondria mediates oxidative stress-induced gating of TRPM2 cation channels. J Biol Chem. 2005;280:6138–6148. [PubMed]
66. Piper RC, Luzio JP. CUPpling calcium to lysosomal biogenesis. Trends Cell Biol. 2004;14:471–473. [PubMed]
67. Pryor PR, Luzio JP. Delivery of endocytosed membrane proteins to the lysosome. Biochim Biophys Acta. 2009;1793:615–624. [PubMed]
68. Pryor PR, Reimann F, Gribble FM, Luzio JP. Mucolipin-1 is a lysosomal membrane protein required for intracellular lactosylceramide traffic. Traffic. 2006;7:1388–1398. [PubMed]
69. Puertollano R, Kiselyov K. TRPMLs: in sickness and in health. Am J Physiol Renal Physiol. 2009;296:F1245–F1254. [PubMed]
70. Riedel KG, Zwaan J, Kenyon KR, Kolodny EH, Hanninen L, Albert DM. Ocular abnormalities in mucolipidosis IV. Am J Ophthalmol. 1985;99:125–136. [PubMed]
71. Ruivo R, Anne C, Sagne C, Gasnier B. Molecular and cellular basis of lysosomal transmembrane protein dysfunction. Biochim Biophys Acta. 2009;1793:636–649. [PubMed]
72. Saito M, Hanson PI, Schlesinger P. Luminal chloride-dependent activation of endosome calcium channels: patch clamp study of enlarged endosomes. J Biol Chem. 2007;282:27327–27333. [PubMed]
73. Samie MA, Grimm C, Evans JA, Curcio-Morelli C, Heller S, Slaugenhaupt SA, Cuajungco MP. The tissue-specific expression of TRPML2 (MCOLN-2) gene is influenced by the presence of TRPML1. Pflugers Arch. 2009;459:79–91. [PMC free article] [PubMed]
74. Schiffmann R, Dwyer NK, Lubensky IA, Tsokos M, Sutliff VE, Latimer JS, Frei KP, Brady RO, Barton NW, Blanchette-Mackie EJ, Goldin E. Constitutive achlorhydria in mucolipidosis type IV. Proc Natl Acad Sci U S A. 1998;95:1207–1212. [PubMed]
75. Sherwood MW, Prior IA, Voronina SG, Barrow SL, Woodsmith JD, Gerasimenko OV, Petersen OH, Tepikin AV. Activation of trypsinogen in large endocytic vacuoles of pancreatic acinar cells. Proc Natl Acad Sci U S A. 2007;104:5674–5679. [PubMed]
76. Singh BB, Lockwich TP, Bandyopadhyay BC, Liu X, Bollimuntha S, Brazer SC, Combs C, Das S, Leenders AG, Sheng ZH, Knepper MA, Ambudkar SV, Ambudkar IS. VAMP2-dependent exocytosis regulates plasma membrane insertion of TRPC3 channels and contributes to agonist-stimulated Ca2+ influx. Mol Cell. 2004;15:635–646. [PubMed]
77. Slaugenhaupt SA, Acierno JS, Jr, Helbling LA, Bove C, Goldin E, Bach G, Schiffmann R, Gusella JF. Mapping of the mucolipidosis type IV gene to chromosome 19p and definition of founder haplotypes. Am J Hum Genet. 1999;65:773–778. [PubMed]
78. Song Y, Dayalu R, Matthews SA, Scharenberg AM. TRPML cation channels regulate the specialized lysosomal compartment of vertebrate B-lymphocytes. Eur J Cell Biol. 2006;85:1253–1264. [PubMed]
79. Soyombo AA, Tjon-Kon-Sang S, Rbaibi Y, Bashllari E, Bisceglia J, Muallem S, Kiselyov K. TRP-ML1 regulates lysosomal pH and acidic lysosomal lipid hydrolytic activity. J Biol Chem. 2006;281:7294–7301. [PubMed]
80. Starkus JG, Fleig A, Penner R. The calcium-permeable non-selective cation channel TRPM2 is modulated by cellular acidification. J Physiol. 2010;588:1227–1240. [PubMed]
81. Sun M, Goldin E, Stahl S, Falardeau JL, Kennedy JC, Acierno JS, Jr, Bove C, Kaneski CR, Nagle J, Bromley MC, Colman M, Schiffmann R, Slaugenhaupt SA. Mucolipidosis type IV is caused by mutations in a gene encoding a novel transient receptor potential channel. Hum Mol Genet. 2000;9:2471–2478. [PubMed]
82. Thompson EG, Schaheen L, Dang H, Fares H. Lysosomal trafficking functions of mucolipin-1 in murine macrophages. BMC Cell Biol. 2007;8:54. [PMC free article] [PubMed]
83. Toth B, Csanady L. Identification of direct and indirect effectors of the transient receptor potential melastatin 2 (TRPM2) cation channel. J Biol Chem. 2010;285:30091–30102. [PMC free article] [PubMed]
84. van de Graaf SF, Chang Q, Mensenkamp AR, Hoenderop JG, Bindels RJ. Direct interaction with Rab11a targets the epithelial Ca2+ channels TRPV5 and TRPV6 to the plasma membrane. Mol Cell Biol. 2006;26:303–312. [PMC free article] [PubMed]
85. van de Graaf SF, Hoenderop JG, Bindels RJ. Regulation of TRPV5 and TRPV6 by associated proteins. Am J Physiol Renal Physiol. 2006;290:F1295–F1302. [PubMed]
86. Venkatachalam K, Hofmann T, Montell C. Lysosomal localization of TRPML3 depends on TRPML2 and the mucolipidosis-associated protein TRPML1. J Biol Chem. 2006;281:17517–17527. [PubMed]
87. Venkatachalam K, Long AA, Elsaesser R, Nikolaeva D, Broadie K, Montell C. Motor deficit in a Drosophila model of mucolipidosis type IV due to defective clearance of apoptotic cells. Cell. 2008;135:838–851. [PMC free article] [PubMed]
88. Venkatachalam K, Montell C. TRP channels. Annu Rev Biochem. 2007;76:387–417. [PubMed]
89. Venugopal B, Browning MF, Curcio-Morelli C, Varro A, Michaud N, Nanthakumar N, Walkley SU, Pickel J, Slaugenhaupt SA. Neurologic, gastric, and opthalmologic pathologies in a murine model of mucolipidosis type IV. Am J Hum Genet. 2007;81:1070–1083. [PubMed]
90. Vergarajauregui S, Connelly PS, Daniels MP, Puertollano R. Autophagic dysfunction in mucolipidosis type IV patients. Hum Mol Genet. 2008;17:2723–2737. [PubMed]
91. Vergarajauregui S, Martina JA, Puertollano R. Identification of the penta-EF-hand protein ALG-2 as a Ca2+-dependent interactor of mucolipin-1. J Biol Chem. 2009;284:36357–36366. [PMC free article] [PubMed]
92. Vergarajauregui S, Martina JA, Puertollano RL. APTMs regulate lysosomal function and interact with Mucolipin-1: new clues for understanting Mucolipidosis Type IV. Journal of Cell Science. 2010 In press. [PubMed]
93. Vergarajauregui S, Oberdick R, Kiselyov K, Puertollano R. Mucolipin 1 channel activity is regulated by protein kinase A-mediated phosphorylation. Biochem J. 2008;410:417–425. [PubMed]
94. Vergarajauregui S, Puertollano R. Two di-leucine motifs regulate trafficking of mucolipin-1 to lysosomes. Traffic. 2006;7:337–353. [PMC free article] [PubMed]
95. Vitner EB, Platt FM, Futerman AH. Common and uncommon pathogenic cascades in lysosomal storage diseases. J Biol Chem. 2010;285:20423–20427. [PMC free article] [PubMed]
96. Xu H, Delling M, Li L, Dong X, Clapham DE. Activating mutation in a mucolipin transient receptor potential channel leads to melanocyte loss in varitint-waddler mice. Proc Natl Acad Sci U S A. 2007;104:18321–18326. [PubMed]
97. Zeevi DA, Frumkin A, Offen-Glasner V, Kogot-Levin A, Bach G. A potentially dynamic lysosomal role for the endogenous TRPML proteins. J Pathol. 2009;219:153–162. [PubMed]
98. Zeevi DA, Lev S, Frumkin A, Minke B, Bach G. Heteromultimeric TRPML channel assemblies play a crucial role in the regulation of cell viability models and starvation-induced autophagy. J Cell Sci. 2010;123:3112–3124. [PubMed]
99. Zhang F, Jin S, Yi F, Li PL. TRP-ML1 functions as a lysosomal NAADP-sensitive Ca2+ release channel in coronary arterial myocytes. J Cell Mol Med. 2009;13:3174–3185. [PMC free article] [PubMed]
100. Zhang F, Li PL. Reconstitution and characterization of a nicotinic acid adenine dinucleotide phosphate (NAADP)-sensitive Ca2+ release channel from liver lysosomes of rats. J Biol Chem. 2007;282:25259–25269. [PubMed]
101. Zhou XL, Batiza AF, Loukin SH, Palmer CP, Kung C, Saimi Y. The transient receptor potential channel on the yeast vacuole is mechanosensitive. Proc Natl Acad Sci U S A. 2003;100:7105–7110. [PubMed]